Sono-Tek Corporation — FY2014 Form 10-K
Business context and reporting period. This annual filing covers the fiscal year ended February 28, 2014 (not a standalone fourth quarter). Sono-Tek develops and sells ultrasonic spray-coating equipment for electronics, advanced energy, medical devices, glass, textiles and food markets. Its separate real estate segment operates the company’s industrial park.
Financial performance
| Metric | FY2014 | FY2013 |
|---|---|---|
| Consolidated revenue | $10.279 million | $9.542 million |
| Gross profit / margin | $4.733 million / 46% | $4.532 million / 48% |
| Operating income | $719,000 | $151,000 |
| Net income | $484,000 | $132,000 |
| Diluted EPS | $0.03 | $0.01 |
| Cash from operations | $1.668 million | $611,000 |
- Consolidated revenue grew about 7.7%; ultrasonic spraying segment sales were $10.202 million, compared with $9.491 million. Gross margin declined, primarily reflecting fewer stent-coating unit sales.
- Operating margin was approximately 7.0%, up from 1.6%; net margin was approximately 4.7%, up from 1.4%. Lower selling and administrative expenses contributed to improved earnings.
- Cash and cash equivalents were $3.232 million and marketable securities were $631,000 at year-end. Working capital was $4.753 million; the current ratio was 3.6, down from 5.3.
- Total debt was $1.671 million, versus $2.113 million a year earlier. This included a $1.589 million, 10-year mortgage at 4.15% following refinancing, and $81,000 of equipment debt. The $750,000 revolving credit line had no borrowings.
- Capital expenditures for equipment and furnishings were $224,000; patent and other asset costs were $56,000. Cash increased $1.291 million during the year.
Changes, outlook and risks
- Net income increased substantially from FY2013, while gross margin fell by two percentage points. Foreign sales rose to $6.447 million, or 63% of revenue, from $5.157 million, or 54%. Sales to Europe increased; Asian and U.S. sales declined slightly.
- Management cited growth in nozzles and generators, WideTrack, XYZ and servo units, solder-recovery systems and spray dryers; stent-coating sales decreased, and fluxer sales eased. The solar market remained slow amid industry overcapacity and reduced government incentives.
- The filing gives no numerical earnings or revenue guidance. Management describes market diversification, new applications and products, and expanded sales and service capabilities as a foundation for growth, while noting that future results depend on demand, new-product adoption, competition, financing and patent protection.
- Foreign markets are material; one customer accounted for about 10% of annual sales, and three customers represented 27% of year-end receivables. The industrial park segment reported a $186,000 net loss; management said leasing vacant space could improve cash flow.
- Refinancing the industrial park mortgage resulted in a $15,000 write-off of impaired financing costs. The company reported no material commitments or contingencies, no legal proceedings, and no off-balance-sheet arrangements. As a smaller reporting company, it did not provide the separate Item 1A risk-factors section.
Investor verification priorities
- Reconcile the MD&A’s ultrasonic-sales figures with consolidated revenue, which also includes real estate activity and eliminations.
- Assess whether improved operating results and operating cash flow are sustainable, especially given lower gross margin and the increase in customer deposits.
- Review mortgage refinancing terms, scheduled debt payments, collateral, and the effect of continued industrial-park vacancies.
- Evaluate exposure to overseas sales, customer concentration, solar-market weakness, and reliance on successful adoption of new applications.
- Confirm subsequent developments: the filing discloses a new 4,000-square-foot tenant lease signed in May 2014, but does not quantify its financial effect.